Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Scoring system may help predict 30-day and one-year mortality following TAVR

Researchers identified predictors of 30-day and one-year mortality in patients who have undergone transcatheter aortic valve replacement (TAVR) and developed a scoring system that may help forecast mortality following TAVR.

Trial examines the Tryton stent for use in patients with large side branches

A prospective study found that the use of the Tryton side branch stent in patients undergoing PCI was effective in treating coronary artery bifurcations involving large side branches.

CMS grants IDE to MedStar for trial examining TAVR devices

The Centers for Medicare & Medicaid Services (CMS) granted the Medstar Research Institute an investigational device exemption to conduct a prospective transcatheter aortic valve replacement (TAVR) trial.

FDA approves Medtronic’s drug-coated balloon in a longer length

The FDA approved new versions of Medtronic’s IN.PACT Admiral drug-coated balloon on July 13 to treat patients with peripheral artery disease.

BayCare Health first to implant world’s smallest pacemaker

BayCare Health System, a nonprofit healthcare provider in Clearwater, Fla., became the first to implant the world’s smallest pacemaker in June.

Thumbnail

Arizona marathon runner receives first dissolvable heart stent

A dissolvable heart stent, just recently approved by the FDA, was implanted into a patient for the first time this week, a significant advancement in cardiovascular care.

Essential Medical gets FDA approval for vascular closure trial

Medical device company Essential Medical has received FDA approval to conduct a clinical trial to study the safety and efficacy of vascular access closures done using its device branded MANTA.

Thumbnail

Cardiologists claim PCIs may not be appropriate to treat stable ischemic heart disease

The cardiologists published a review of PCIs online in JAMA Internal Medicine on July 5 and argued that PCIs may not be best to treat patients with stable ischemic heart disease.

Displaying 1361 - 1368 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.